This compound is primarily utilized in pharmaceutical research and development, particularly in the synthesis of chiral molecules. Its structure, featuring a fluorine atom and a 1-aminoethyl group, makes it a valuable intermediate in the creation of active pharmaceutical ingredients (APIs) targeting neurological and psychiatric disorders. It is often employed in the development of selective enzyme inhibitors or receptor modulators due to its ability to interact with specific biological targets. Additionally, its chiral nature allows for the production of enantiomerically pure drugs, enhancing efficacy and reducing side effects. Researchers also explore its potential in radiopharmaceuticals for diagnostic imaging, leveraging the fluorine atom for positron emission tomography (PET) applications.